Clarametyx Biosciences

Columbus, OH · Founded 2019 · Privately Held (backing)

Developer of immune-facilitated biologic therapies designed to fight life-threatening infections. Clarametyx Biosciences is based in Columbus, OH and was founded in 2019. It was valued at $92 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $44 million across 1 recorded round; the latest was a $27.5 million early-stage round in Jan 2024.

PMV mark · valuation
$92.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$44.0M
Last round
Early Stage VC
Jan 2024
How much has Clarametyx Biosciences raised?
$44.0Macross 1 recorded rounds · Jan 2024 – Jan 2024

Most recently, Clarametyx Biosciences raised $27.5M in its Early Stage VC (Jan 2024).

Free account
More of Clarametyx Biosciences with a free account
  • ·Watch Clarametyx Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Clarametyx Biosciences round by round

1 rounds
Jan 2024Early Stage VC$27.5MSEC filing▮
7 investors participated

How much has Clarametyx Biosciences raised?

Clarametyx Biosciences has raised $44 million in total; 1 of its rounds is on record. The largest on record was a $27.5 million early-stage round in Jan 2024.

Clarametyx Biosciences has filed 1 Form D with the SEC, most recently in Jan 2024 ($27.5 million sold to 7 investors).

Clarametyx Biosciences investors

8 investors are on record for Clarametyx Biosciences, including JobsOhio Ventures, Rev1 Ventures, CincyTech and CARB-X. The early-stage round in Jan 2024 drew 7 investors.

For fundraisers
Raising for a company like Clarametyx Biosciences?

8 investors have backed Clarametyx Biosciences.

See all 8 investors →

Frequently asked about Clarametyx Biosciences

How much has Clarametyx Biosciences raised?
Clarametyx Biosciences has raised $44.0M in total across 1 recorded funding rounds.
When was Clarametyx Biosciences's last funding round?
Clarametyx Biosciences's most recent recorded round was Early Stage VC in Jan 2024, raising $27.5M.